Scottish Medicines Consortium (SMC) approves Opicapone for use in NHS Scotland Date 17 January 2022 Opicapone could help people whose main Parkinson’s medications are "wearing off" before the next dose is due, a common problem which has a huge impact on quality of life.
What we achieved in 2021, together Date 21 December 2021 It’s been another tough year. Especially if you, or someone you love, has Parkinson’s. But we’re learning to live with coronavirus, adapting our vital support services and finding new ways to come together as a community.
Working together to drive forward race equality in research Date 21 December 2021 We’ve teamed up with leading patient engagement organisations COUCH Health and Egality Health to make Parkinson’s research more accessible, relevant and inclusive.
Take part in groundbreaking research to test drugs to combat coronavirus Date 14 December 2021 If you test positive for coronavirus, you may be able to take part in a UK-wide trial to find out if antiviral drugs can help people recover faster.
Caption Research pipette Parkinson's protein test could lead to earlier and better diagnosis Date 13 December 2021 Scientists have shown a pioneering test could diagnose Parkinson's correctly in its early stages.
We're investing up to £3m in drugs that could slow the progression of Parkinson’s Date 6 December 2021 We’re investing in research into inflammation that could help develop drugs that slow the progression of Parkinson’s, something no current medication can do.
Government announces reform of social care in England Date 3 December 2021 The UK government has published its long-awaited White Paper on social care reform in England, People at the Heart of Care.
Caption Baroness Gale and Barbara Deering in parliament APPG on Parkinson’s marks UK Disability History Month 2021 Date 2 December 2021 The co-chairs of the All-Party Parliamentary Group on Parkinson's share their support for Disability History Month
Clinical trial of new dyskinesia drug starts in Sweden Date 30 November 2021 The first participant has been recruited to a pioneering clinical trial which is testing a new drug called NLX-112 to investigate its potential for people with Parkinson’s.
Working together to put patients at the heart of Parkinson's research Date 26 November 2021 UCB, a global pharmaceutical company, has joined forces with Parkinson's UK, and the Parkinson's Foundation in the US, to establish a Patient Engagement Council for Parkinson's Research.
